Authors: Eng Hooi Tan, Anthony G Sena, Albert Prats-Uribe, Seng Chan You, Waheed-Ul-Rahman Ahmed, Kristin Kostka, Christian Reich, Scott L Duvall, Kristine E Lynch, Michael E Matheny, Talita Duarte-Salles, Sergio Fernandez Bertolin, George Hripcsak, Karthik Natarajan, Thomas Falconer, Matthew Spotnitz, Anna Ostropolets, Clair Blacketer, Thamir M Alshammari, Heba Alghoul, Osaid Alser, Jennifer C E Lane, Dalia M Dawoud, Karishma Shah, Yue Yang, Lin Zhang, Carlos Areia, Asieh Golozar, Martina Recalde, Paula Casajust, Jitendra Jonnagaddala, Vignesh Subbian, David Vizcaya, Lana Y H Lai, Fredrik Nyberg, Daniel R Morales, Jose D Posada, Nigam H Shah, Mengchun Gong, Arani Vivekanantham, Aaron Abend, Evan P Minty, Marc Suchard, Peter Rijnbeek, Patrick B Ryan, Daniel Prieto-Alhambra

Venue: Rheumatology

Type: Article

Abstract: Patients with autoimmune diseases were advised to shield to avoid coronavirus disease 2019 (COVID-19), but information on their prognosis is lacking. We characterized 30-day outcomes and mortality after hospitalization with COVID-19 among patients with prevalent autoimmune diseases, and compared outcomes after hospital admissions among similar patients with seasonal influenza. A multinational network cohort study was conducted using electronic health records data from Columbia University Irving Medical Center [USA, Optum (USA), Department of Ve... (read more)

DOI: 10.1093/rheumatology/keab250